| 摘要 |
<p>An oncostatic drug which contains as the effective ingredient a polyacid salt of molybdenum or a heteropolyacid salt thereof with tungsten represented by the general formulae (I) to (III): [A]m[MOx Oy Hz]n.lH2O (I); [B]p[MOu Ow(O2)t(OH)v].KH2O (II); [D]qHr[XMO sW6-sO24] (III), wherein A represents alpha (wherein R<1> to R<4> each represents a lower alkyl), an alkali metal, or a mixture of an alkali metal with an other alkali metal, H, NH4 or an alkylammonium, B and D each represents an alkali metal, NH4 or an alkylammonium, X represents I, Cr, Co, Pt, Te, Ni, Mn, Al, Ga, Zn, Fe or Cu, and m, n, p, q, r, s, t, u, v, w, x, y and z each represents 0 or an integer.</p> |
